News Release

St. Louis, MO – July 24, 2002 -- Amdocs Limited (NYSE: DOX) today reported that for the third quarter ended June 30, 2002, revenue reached $380.1 million, a decrease of 5.9% from last year's third quarter. Excluding acquisition-related costs, net income decreased 39.6% to $44.7 million, while earnings per share decreased 39.4% to $0.20 per diluted share, compared to net income of $74.1 million, or $0.33 per diluted share, in the third quarter of fiscal 2001. The Company's as-reported results, which include acquisition-related charges for amortization of goodwill and purchased intangible assets and related tax effects, showed a net loss of $26.9 million, or $0.12 per diluted share, compared to net income of $18.5 million, or $0.08 per diluted share, in the third quarter of fiscal 2001.

In response to the Company’s reduced revenue levels, management has moved quickly to implement a plan cutting overall costs by 10%. As part of this, Amdocs completed its previously announced manpower reductions, trimming approximately 900 personnel shortly after the close of the quarter.

Dov Baharav, Chief Executive Officer of Amdocs Management Limited, said, "During the quarter, we saw a significant deterioration in the telecom market and a commensurate deterioration in our market. Closing new deals became increasingly difficult and we closed five new wins this quarter, fewer than expected. Certain customers made smaller initial commitments. In addition, some existing customers reduced discretionary expenses, which impacted our revenue. Despite the slowdown, we believe that we are maintaining market share, albeit in a smaller market. Our pipeline is large with a number of high quality prospects but, clearly, the ongoing issue is conversion to signed deals. Our new management team is fully in place and keenly focused on driving the changes required in our business to enhance shareholder value. I am confident that we will be well positioned for renewed growth when the industry recovers.”

The Company repurchased over seven million shares during the third quarter for approximately $94 million.

Sales Highlights

During the third quarter, Amdocs won five new projects:

• Amdocs Enabler to support 3G for existing customer in Europe
• For existing billing customer – Amdocs ClarifyCRM for North American mobile operator
• End-to-end billing system for wireline operator
• Enabler-based upgrade for 3G at existing customer in North America
• Significant expansion of products and services provided to major wireline customer

Operating Highlights

• Vodafone UK implements ClarifyCRM, integrated with Amdocs billing systems
• Vimpelcom, mobile operator in Russia, goes live with Amdocs end-to-end customer care and billing
• Cingular implements Amdocs end-to-end customer care and billing in Great Lakes region and Upstate New York market
• Amdocs Enabler delivered to major European mobile operator
• Amdocs ClarifyCRM wins Best CRM award at TeleStrategies Billing World 2002
• Amdocs ClarifyCRM implemented at Netia in Poland
• Release of version 4.0 of Fraud Management
• Tess in Brazil implements Amdocs fraud management system
• Cash, cash equivalents and short-term interest-bearing investments grew by $66 million in the third quarter, excluding the $94 million used for the share repurchase

Financial Outlook

Amdocs is reiterating the guidance provided on June 20, 2002. The Company expects that revenue for the fourth quarter ending September 30, 2002, will be approximately $350-$360 million. Amdocs will record a one-time charge of approximately $20-$25 million in the fourth quarter related primarily to manpower reductions. Pro forma earnings per share for the quarter are expected to be approximately $0.17-$0.20, excluding acquisition-related costs and the nonrecurring charge related to manpower reductions. Including the acquisition-related costs and the non-recurring charge related to the manpower reductions, the Company will incur a net loss in the fourth quarter.

Amdocs will host a conference call on July 24, 2002 at 5 p.m. Eastern Daylight Time to discuss the Company's third quarter results. The call will be carried live on the Internet via www.vcall.com and the Amdocs website, www.amdocs.com.

About Amdocs

Amdocs is the world-leading provider of billing and CRM to the communications industry. Amdocs offers pre-integrated products, customized solutions and outsourcing services with time-to-market advantages and advanced support for next-generation services. With a 20-year track record of delivery excellence, Amdocs provides competitive software solutions, which enable its global customer base to achieve profitable growth, improved customer loyalty and lower total cost of ownership. For more information, visit Amdocs at www.amdocs.com.

This press release may contain forward-looking statements as defined under the Securities Act of 1933, as amended, including statements about Amdocs' growth and business results in future quarters. Although we believe the expectations reflected in such forward-looking statements are based upon reasonable assumptions, we can give no assurance that our expectations will be obtained or that any deviations will not be material. Such statements involve risks and uncertainties that may cause future results to differ from those anticipated. These risks include, but are not limited to, the effects of general economic conditions, Amdocs' ability to grow in the mobile, wireline and IP business segments, adverse effects of market competition, rapid technological shifts that may render the Company's products and services obsolete, potential loss of a major customer, our ability to develop long-term relationships with our customers, and risks associated with operating businesses in the international market. These and other risks are discussed at greater length in the Company's filings with the Securities and Exchange Commission, including in our Annual Report on Form 20-F filed December 27, 2001 and our Form 6-K filed on May 13, 2002.

Contact:
Thomas G. O’Brien
Treasurer and Director of Investor Relations
Amdocs Limited
314/212-8328
E-mail: dox_info@amdocs.com